At renal level, the CYP1B1 overexpression induced in RPTEC by tARPC can be interpreted as an attempt to protect RPTEC from cisplatin-induced nephrotoxicity and may open an important strategy of prevention of AKI before starting chemotherapy. Here, CYP1B1 is linked to acute kidney injury.